TWO SIGMA INVESTMENTS, LP - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$130,176
-53.2%
90,400
-12.9%
0.00%
-100.0%
Q1 2023$278,138
-87.3%
103,783
-74.3%
0.00%
-85.7%
Q4 2022$2,189,935
-33.1%
403,303
+53.8%
0.01%
-36.4%
Q3 2022$3,275,000
+492.2%
262,182
+134.2%
0.01%
+450.0%
Q2 2022$553,000
+203.8%
111,932
+368.6%
0.00%
+100.0%
Q1 2022$182,000
-86.9%
23,885
-82.5%
0.00%
-66.7%
Q4 2021$1,391,000
+22.3%
136,235
+60.8%
0.00%0.0%
Q3 2021$1,137,000
-91.7%
84,731
-86.5%
0.00%
-90.3%
Q2 2021$13,729,000
-31.8%
625,754
-25.3%
0.03%
-40.4%
Q1 2021$20,145,000
+296.4%
837,276
+196.4%
0.05%
+246.7%
Q4 2020$5,082,000
+169.5%
282,475
+73.0%
0.02%
+114.3%
Q3 2020$1,886,000
+41.4%
163,310
+34.9%
0.01%
-36.4%
Q1 2020$1,334,000
-24.5%
121,049
+81.0%
0.01%
+120.0%
Q4 2019$1,767,000
+582.2%
66,871
+487.6%
0.01%
+400.0%
Q3 2019$259,000
-87.9%
11,380
-91.2%
0.00%
-85.7%
Q1 2019$2,148,000
+47.8%
129,420
+70.6%
0.01%
+16.7%
Q4 2018$1,453,000
-7.3%
75,857
+79.3%
0.01%
+20.0%
Q1 2018$1,567,000
+217.8%
42,305
+70.1%
0.01%
+150.0%
Q4 2017$493,00024,8730.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders